A Prospective Controlled Study on the Effect on Bleeding Events and Joint Function in Young Adults With Severe Hemophilia A After a 6 Month Prophylaxis Treatment Compared to on Demand Treatment.

Trial Profile

A Prospective Controlled Study on the Effect on Bleeding Events and Joint Function in Young Adults With Severe Hemophilia A After a 6 Month Prophylaxis Treatment Compared to on Demand Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs Octocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 19 Nov 2009 Actual patient number changed from (50) to (20) added as reported by ClinicalTrials.gov.
    • 24 Sep 2008 Actual end date 1 Mar 2008 added as reported by CT.gov
    • 24 Sep 2008 Status changed from active, no longer recruiting to completed as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top